Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Mike Cole

Newcastle AuthorsTitleYearFull text
Dr Stefan Siebert
Dr Arthur Pratt
Dr Deborah Stocken
Dr Miranda Morton
Amy Cranston
et al.		Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial2020
Mike Cole
Dr Ann Marie Hynes
Denise Howel
Dr Lesley Hall
Dr Mario Abinun
et al.		Adjuvant rituximab, a potential treatment for the young patient with Graves’ hyperthyroidism (RiGD): study protocol for a single-arm, single-stage, phase II trial2019
Professor Jeremy Parr
Dr Emma Todhunter
Dr Lindsay Pennington
Dr Deborah Stocken
Dr Jill Cadwgan
et al.		Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability2018
Professor Vinidh Paleri
Dr Joanne Patterson
Dr Deborah Stocken
Mike Cole
Professor Luke Vale
et al.		A feasibility study incorporating a pilot randomised controlled trial of oral feeding plus pre-treatment gastrostomy tube versus oral feeding plus as-needed nasogastric tube feeding in patients undergoing chemoradiation for head and neck cancer (TUBE trial): study protocol2016
Dr Sarah Fordham
Mike Cole
Professor Julie Irving
Professor James Allan
Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia2015
Dr Ashleigh Herriott
Dr Susan Tudhope
Gesa Junge
Natalie Rodrigues
Dr Miranda Morton
et al.		PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in Chronic Lymphocytic Leukaemia2015
Dr Sarah Fordham
Mike Cole
Professor Julie Irving
Professor James Allan
Cytarabine leaves a mutational fingerprint in relapsing leukemia2014
Dr Jess Dyson
Dr Dipanker Chattopadhyay
Rajiv Lochan Jayadeva
Dr Imran Patanwala
Mike Cole
et al.		Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team2014
Professor Gareth Veal
Julie Errington
Sophie Rowbotham
Nicola Illingworth
Dr Ghada Malik
et al.		Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma2013
Dr Sarra Ryan
Dr Ed Schwalbe
Mike Cole
Yuan Lu
Dr Meryl Lusher
et al.		MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma2012
12345678